Position in AZN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$338,282
-$46,099 QoQ
Shares Held
1,784
-8.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#996
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Great Diamond Partners, LLC holds $13,795,982 across 8 Drug Manufacturers - General names. AZN ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,752 | $4,500,261 | |
| 2 | AMGN |
Amgen Inc
|
10,339 | $3,743,958 | |
| 3 | JNJ |
Johnson & Johnson
|
6,236 | $1,583,756 | |
| 4 | ABBV |
AbbVie Inc.
|
5,368 | $1,350,803 | |
| 5 | MRK |
Merck & Co., Inc.
|
9,602 | $1,233,857 | |
| 6 | NVO |
Novo Nordisk A S
|
13,715 | $657,497 | |
| 7 | NVS |
Novartis AG
|
2,473 | $387,568 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
1,784 | $338,282 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $338,282 | 1,784 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $384,381 | 1,949 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||